Pliant Therapeutics, Inc.
PLRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001746473
No open-market purchases or sales by Pliant Therapeutics, Inc. insiders were filed in the last 90 days; 86 institutions reported holding it in 13F filings for Q2 2026, worth $54.8M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Pliant Therapeutics, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 98 | 4 | 91 | −3 |
| Shares | 46.7M | 2.91M | 49.7M | +5.85M (+13.4%) |
| Value | $57.0M | $3.55M | $62.5M | +$9.07M (+17.0%) |
4 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (14)
Institutions that held Pliant Therapeutics, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Capital Management LLC | 2,343,101 | $2.95M | 0.00% |
| DAFNA Capital Management LLC | 487,000 | $613.6K | 0.14% |
| Vanguard Fiduciary Trust Co | 339,540 | $427.8K | 0.00% |
| Vanguard Portfolio Management LLC | 153,810 | $193.8K | 0.00% |
| Verdad Advisers, LP | 98,320 | $123.9K | 0.14% |
| Ameriprise Financial Inc | 55,129 | $69.5K | 0.00% |
| Public Employees Retirement System of Ohio | 28,500 | $35.9K | 0.00% |
| Vanguard Global Advisers, LLC | 19,507 | $24.6K | 0.00% |
| Tower Research Capital LLC (TRC) | 3,315 | $4.18K | 0.00% |
| Owl Creek Wealth Partners LLC | 2,300 | $2.90K | 0.00% |
| Harbour Investments, Inc. | 488 | $615 | 0.00% |
| Northwestern Mutual Wealth Management Co | 100 | $126 | 0.00% |
| Fifth Third Bancorp | 4 | $5 | 0.00% |
| Capital Advisors, Ltd. LLC | 20 | $0 | 0.00% |
Sold out (17)
Institutions that held Pliant Therapeutics, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Two Sigma Advisers, LP | 1,245,600 | $1.52M |
| Seven Fleet Capital Management LP | 276,500 | $337.3K |
| Rice Hall James & Associates, LLC | 147,705 | $180.2K |
| Diadema Partners LP | 144,914 | $176.8K |
| Canada Pension Plan Investment Board | 61,400 | $74.9K |
| Deeter Investments LLP | 48,025 | $58.6K |
| Persistent Asset Partners Ltd | 38,831 | $47.4K |
| Engineers Gate Manager LP | 30,544 | $37.3K |
| Group One Trading, L.P. | 15,790 | $19.3K |
| Quest Partners LLC | 11,716 | $14.3K |
| Fortitude Family Office, LLC | 1,278 | $1.56K |
| The PNC Financial Services Group, Inc. | 978 | $1.19K |
| Russell Investments Group, Ltd. | 542 | $661 |
| Bare Financial Services, Inc | 413 | $504 |
| Cornerstone Financial Management LLC | 319 | $389 |
| Covestor Ltd | 45 | $0 |
| DekaBank Deutsche Girozentrale | 40,000 | – |
Not filed for Q1 2026 yet (4)
Institutions that held Pliant Therapeutics, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 2,818,241 | $3.44M |
| Kotler Kevin | 93,000 | $113.5K |
| Comerica Bank | 6 | $7 |
| Global Retirement Partners, LLC | 4 | $5 |